Cargando…
Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
BACKGROUND: We aimed to determine whether cerebral white matter hyperintensities (WMHs) can distinguish stroke survivors susceptible to rapid kidney function decline from intensive blood pressure (BP) lowering. METHODS AND RESULTS: The SPS3 (Secondary Prevention of Small Subcortical Strokes) trial r...
Autores principales: | Ikeme, Jesse C., Pergola, Pablo E., Scherzer, Rebecca, Shlipak, Michael G., Catanese, Luciana, McClure, Leslie A., Benavente, Oscar R., Peralta, Carmen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405594/ https://www.ncbi.nlm.nih.gov/pubmed/30686103 http://dx.doi.org/10.1161/JAHA.118.010091 |
Ejemplares similares
-
CYP2C19 Metabolizer Status and Clopidogrel Efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) Study
por: McDonough, Caitrin W, et al.
Publicado: (2015) -
Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke
por: Jiang, Jingwen, et al.
Publicado: (2022) -
Spatial Signature of White Matter Hyperintensities in Stroke Patients
por: Schirmer, Markus D., et al.
Publicado: (2019) -
The association of white matter hyperintensities with stroke outcomes and antiplatelet therapy in minor stroke patients
por: Xu, Yu-Yuan, et al.
Publicado: (2020) -
White Matter Hyperintensities and Cognitive Dysfunction in Patients With Infratentorial Stroke
por: Kim, Tae Won, et al.
Publicado: (2014)